Inc. (NASDAQ:AMRS), a leading renewable chemicals and fuels company,
today unveiled EvoShieldTM,
its new product line of industrial lubricants. The announcement was made
during a speech delivered by Amyris CEO John Melo at the Infineon
Raceway of Sonoma's inaugural Accelerating
Sustainable Performance Summit.
EvoShield lubricants are a family of renewably-sourced solutions
designed to satisfy the most advanced lubrication challenges without
compromising quality or performance. EvoShield lubricants will be
formulated from NovaSpecTM renewably-sourced synthetic base
oils, derived from Amyris's Biofene®and produced by Novvi,
Amyris's joint venture with Brazil's Cosan.
"Novvi's high-performance base oils, combined with advanced additive
systems, will enable Amyris EvoShield products to perform in a range of
applications under extreme conditions of temperature, moisture, dirt and
wear, while improving upon key environmental metrics including
renewability, toxicity and biodegradability when compared with
petroleum-sourced lubricants," said John Melo, CEO of Amyris. "We are on
track to begin production this year and to redefine performance for the
These lubricants will provide ideal protection for equipment across a
broad range of industrial applications, including hydraulic, compressor,
turbine and gear oils, as well as specific formulations for marine and
"The Infineon Summit provides the ideal environment and platform to
announce our new line of renewably-sourced, high-performance industrial
lubricants," said Jim Richardson, president of lubricants and fuels for
Amyris. "Motorsports require the highest-performing products to deliver
under challenging and extreme conditions. These performance expectations
are consistent with the needs of our industrial customers in a variety
of different applications and we're excited to introduce EvoShield's
capabilities at an event that emphasizes sustainability and highlights
our environmental improvements over petroleum-based lubricants."
As the Official Renewable Fuels Provider of the Raceway, Amyris also
showcased the performance of its renewable diesel during the summit by
powering a 2011 Audi Q7 TDI around the track. This demonstration marked
the first on-road operation of a vehicle fueled by 100 percent neat
Amyris renewable diesel.
Amyris is scaling its Biofene production in Brazil, Europe and the
United States through five production arrangements, including
manufacturing agreements with Antibióticos S.A., Biomin do Brasil
Nutri?ão Animal Ltda., Paraíso Bioenergia S.A., Tate & Lyle and a joint
venture with Usina São Martinho S.A., one of the largest sugar and
ethanol producers in Brazil. Amyris has also established finishing
capabilities with Glycotech, Inc. in North Carolina.
About Amyris, Inc.
Amyris is an integrated renewable products company focused on providing
sustainable alternatives to a broad range of petroleum-sourced products.
Amyris uses its industrial synthetic biology platform to convert plant
sugars into a variety of hydrocarbon molecules - flexible building
blocks that can be used in a wide range of products. Amyris is
commercializing these products both as No Compromise® renewable
ingredients in cosmetics, flavors and fragrances, polymers, lubricants
and consumer products, and also as No Compromise renewable diesel and
jet fuel. Amyris Brasil Ltda., a subsidiary of Amyris, oversees the
establishment and expansion of Amyris's production in Brazil. Amyris
also has fuel distribution capabilities in the United States through its
subsidiary, Amyris Fuels, LLC. More information about Amyris is
available at www.amyris.com.
This release contains forward-looking statements, and any statements
other than statements of historical facts could be deemed to be
forward-looking statements. These forward-looking statements include,
among other things, statements regarding future events (such as
statements regarding the performance attributes and environmental
benefits of our lubricants products and the timing of their production)
that involve risks and uncertainties. These statements are based on
management's current expectations and actual results and future events
may differ materially due to risks and uncertainties, including those
associated with any delays or failures in development, production or
commercialization of products, our reliance on third parties to achieve
our goals, and other risks detailed in the "Risk Factors" section of
Amyris's annual report on Form 10-K filed on March 14, 2011 and
quarterly reports on Form 10-Q filed on May 11, 2011 and August 11,
2011. Amyris disclaims any obligation to update information contained in
these forward-looking statements whether as a result of new information,
future events, or otherwise.
Amyris, Biofene, EvoShield, and No Compromise are trademarks or
registered trademarks of Amyris, Inc.
Merrill Freund or Alison Mickey,